机器人非停跳全内镜下冠状动脉旁路移植术:544例报告
该研究回顾性分析了2013年7月至2020年8月期间544例接受机器人非停跳全内镜下冠状动脉旁路移植术(TECAB)的患者数据。结果显示死亡率为0.9%,早期桥血管通畅率为97%,中位随访38个月时心脏死亡率为2.7%,无主要不良心脏事件生存率为92.5%。结论认为该术式在经验丰富的团队中安全有效,早期通畅率与标准冠脉搭桥相当。
要点
- 机器人非停跳TECAB死亡率为0.9%,早期桥血管通畅率97%。
- 中位随访38个月,心脏死亡率2.7%,无MACE生存率92.5%。
核心结论
- 机器人非停跳TECAB在经验丰富的团队中安全有效,早期血管造影通畅率与标准冠脉搭桥相当。
研究设计与样本
- 回顾性研究,纳入2013年7月至2020年8月期间544例接受机器人非停跳TECAB的患者,每年进行随访。
主要发现
- 1例中转开胸,46%在手术室拔管,死亡率为0.9%。
- 早期桥血管通畅率为97%,中位随访38个月时心脏死亡率为2.7%,无主要不良心脏事件生存率为92.5%。
关键数值与推荐
- 70%的桥血管使用C-Port Flex-A远端吻合装置。
- 早期桥血管通畅率为97%,中位随访38个月时无主要不良心脏事件生存率为92.5%。
临床怎么用
- 对于适合的患者,机器人非停跳TECAB可由经验丰富的团队安全实施,获得与标准冠脉搭桥相当的早期通畅率。
局限性
- 回顾性设计,需要更长期的研究来评估远期效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Robotic off-pump totally endoscopic coronary artery bypass (TECAB) is the least invasive form of surgical coronary revascularization. It has proved to be highly effective and safe. Its benefits are well-established and include fewer complications, shorter hospital stay and quicker return to normal activities. TECAB has undergone 2 decades of technological advancement to include multivessel grafting, a beating-heart approach and successful completion in multiple patient groups in experienced hands. The aim of this report was to examine outcomes of robotic off-pump TECAB at our institution over 7 years. METHODS: Data from 544 patients undergoing TECAB between July 2013 and August 2020 were retrospectively examined. The C-Port Flex-A distal anastomotic device was used for the majority of grafts (70%). Yearly follow-up was conducted. Angiographic early patency data were reviewed for patients undergoing hybrid revascularization. RESULTS: The mean age was 66 years, with 1.7% mean STS risk. Fifty-six percentage had multivessel TECAB. There was 1 conversion to sternotomy, and 46% extubation in the Operating Room (OR). Mortality was 0.9%. Early graft patency was 97%. At mid-term follow-up at 38 months, cardiac mortality was 2.7% and freedom from major adverse cardiac events was 92.5%. CONCLUSIONS: We conclude that robotic beating-heart TECAB in the current era is safe and effective with excellent outcomes and comparable early angiographic patency to standard coronary artery bypass grafting surgery when performed frequently by an experienced team. This procedure was completed in our hands both with and without an anastomotic device. Longer-term studies are warranted.
引用
- Balkhy HH, Nisivaco S, Kitahara H, et al. Robotic off-pump totally endoscopic coronary artery bypass in the current era: report of 544 patients. Eur J Cardiothorac Surg. 2022. PMID: 34392341. doi:10.1093/ejcts/ezab378
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。